doi: 10.1002/ijc.21685
As we age, our natural production of glutathione, the body's master antioxidant, declines, leaving us more vulnerable to fatigue, toxins, and oxidative stress.* But you can fight back
Safety data for injectable glutathione during pregnancy and lactation are limited
As two negative regulators of p53, MDM2 and MDMX facilitate ferroptosis with or without p53, most likely by altering the lipid profile of cells (Venkatesh et al., 2020), which is confirmed by evidence that with the treatment of MDM2 inhibitor nutlin-3, p53 expression increases and leads to the suppression of X c system inhibitor-induced ferroptosis in HT-1080 cells (Tarangelo et al., 2018)
The most common side effects appear to be related to the method of administration, which is typically intramuscular or subcutaneous injection
This is likely due to glutathione's role in cellular energy production and its ability to reduce cellular stress